title: Intrathecal mitozantrone has to be prohibited.
authors.forename: J H
authors.initials: JH
authors.lastname: Dalle
authors.forename: A
authors.initials: A
authors.lastname: Lambilliotte
authors.forename: A S
authors.initials: AS
authors.lastname: Defachelles
authors.forename: F
authors.initials: F
authors.lastname: Mazingue
authors.forename: B
authors.initials: B
authors.lastname: Nelken
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007278:Injections, Spinal; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage / Q000009:adverse effects*; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D008942:Mitoxantrone